| X23-12-YM1021 |
Azilsartan medoxomil
|
|
| X23-12-YM1084 |
Fimasartan
|
|
| X23-12-YM1088 |
Losartan
|
|
| X23-12-YM1304 |
Azilsartan medoxomil monopotassium
|
|
| X23-12-YM1306 |
Sparsentan
|
|
| X23-12-YM1317 |
AVE 0991
|
|
| X23-12-YM1381 |
Losartan (D4 carboxylic acid)
|
|
| X23-12-YM1384 |
Azilsartan D5
|
|
| X23-12-YM456 |
Irbesartan
|
|
| X23-12-YM488 |
Tasosartan
|
|
| X23-12-YM492 |
Valsartan
|
|
| X23-12-YM505 |
Eprosartan
|
|
| X23-12-YM600 |
Azilsartan
|
|
| X23-12-YM749 |
PD 123319 ditrifluoroacetate
|
|
| X23-12-YM802 |
SL910102
|
|
| X23-12-YM865 |
BIBS39
|
|
| X23-12-YM877 |
LCZ696
|
|
| X24-06-ZQ564 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor CGP 60536, Purity ≥98%
|
|
| X24-06-ZQ565 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor Aliskiren hemifumarate, Purity ≥98%
|
|
| X24-06-ZQ572 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor Angiotensin 1/2 (1-5), Purity ≥98%
|
|
| X24-06-ZQ573 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor Angiotensin 1/2 (1-6), Purity ≥98%
|
|
| X24-06-ZQ574 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor Angiotensin 1/2 + A (2-8), Purity ≥98%
|
|
| X24-06-ZQ596 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor Benazepril HCl, Purity ≥98%
|
|
| X24-06-ZQ605 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor Candesartan, Purity ≥98%
|
|
| X24-06-ZQ606 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor Candesartan cilexetil, Purity ≥98%
|
|
| X24-06-ZQ608 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor Captopril, Purity ≥98%
|
|
| X24-06-ZQ609 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor Captopril disulfide, Purity ≥98%
|
|
| X24-06-ZQ612 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor CGP-42112, Purity ≥98%
|
|
| X24-06-ZQ636 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor Enalaprilat dihydrate, Purity ≥98%
|
|
| X24-06-ZQ642 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor Eprosartan mesylate, Purity ≥98%
|
|
| X24-06-ZQ652 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor EXP-3174, Purity ≥98%
|
|
| X24-06-ZQ747 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor Olmesartan, Purity ≥98%
|
|
| X24-06-ZQ748 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor Olmesartan medoxomil, Purity ≥98%
|
|
| X24-06-ZQ775 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor Spinorphin, Purity ≥98%
|
|
| X24-06-ZQ791 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor Telmisartan, Purity ≥98%
|
|
| X24-06-ZQ801 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor VTP-27999 2,2,2-trifluoroacetate, Purity ≥98%
|
|
| X24-09-YM293 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor, Clinofibrate, Purity ≥98%
|
|
| X24-09-YM621 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor, Enalapril maleate, Purity ≥98%
|
|
| X24-09-YM622 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor, Perindopril erbumine, Purity ≥98%
|
|
| X24-09-YM623 |
Renin-angiotensin-aldosterone system (RAAS) inhibitor, Ramipril, Purity ≥98%
|
|
